Theme preview

Cancer Therapeutics

Explore established drugmakers and specialist biotech companies developing and selling cancer treatments.

About this theme

Membership reflects a company's therapeutic focus. It does not indicate the stage or the success of any clinical trial: TickerWhale holds no clinical-trial data and this list must not be read as tracking one.

Research as of the 2026-09-18 publication.

Covered

companies

Average score

62.7/100

mean of 11 scored companies

Today

3↑ 10↓

breadth at the close

The companies, strongest first

EXEL Exelixis-0.2%81 INCY Incyte-1.8%81 BMY Bristol-Myers Squibb Company+0.3%68 IDYA Ideaya Biosciences-0.5%67 JAZZ Jazz Pharmaceuticals-1.3%66 AMGN AMGEN+1.6%62 JNJ Johnson & Johnson-0.1%62 AZN Astrazeneca-0.0%58 PFE Pfizer+0.1%54 MRK Merck & Co-0.2%52

The full theme is free with an account.

Every company in Cancer Therapeutics with its full research — scores, technicals, news and the model’s own read — plus the daily brief and Ask Willy. No card, no app to download.

Start free

Model Targets are a Pro feature; one company’s full target is free every trading day on the Model Target page.